Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness
✍ Scribed by Luca Hegedüs; Hyojin Cho; Xian Xie; George L. Eliceiri
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 128 KB
- Volume
- 216
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We are interested in two aspects of a given type of metastatic breast cancer: which potentially cancer‐relevant genes are expressed and which factors determine invasiveness. Using reverse transcription real‐time PCR, we detected gene expression of 26 matrix metalloproteinases (MMPs) in MDA‐MB‐231 breast cancer cells, including those of MMP‐12, MMP‐16 variant 2, MMP‐19, MMP‐20, MMP‐21, MMP‐23, MMP‐24, MMP‐25, MMP‐25 variant 2, MMP‐L1, MMP‐26, MMP‐27, and MMP‐28, in contrast to the 13 MMPs detected until now in these cells. We found that MMP genes are expressed at widely different levels in these cells, over five orders of magnitude. After individual siRNA‐induced depletions, we found that six additional species of cancer cell MMPs promote invasiveness in MDA‐MB‐231 cells: MMP‐3, MMP‐11, MMP‐12, MMP‐17, MMP‐19, and MMP‐23, thus raising the total to 12 endogenous MMPs which do so in these cells. The data support the conclusion that some cancer cell MMPs, although expressed at low levels, are needed for cancer trait in MDA‐MB‐231 cells, and that several endogenous MMPs play non‐redundant roles in this process. The mRNA level of MMP‐11, but not of other MMPs, rose substantially following individual siRNA‐targeted depletion of cancer cell MMP‐17 mRNA, while no MMP mRNA increased appreciably after degradation of other MMP mRNAs. This supports the conclusion that MMP‐17 may be a member of an intracellular signaling pathway which downregulates MMP‐11 mRNA. J. Cell. Physiol. 216: 480–485, 2008. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Two types of VEGFR‐1 receptors have been characterized: a full‐length transmembrane receptor and a truncated extracellular soluble isoform (sVEGFR‐1). We report here the characterization, in normal and cancer cells, of a new family of intracellular isoforms of VEGFR‐1 resulting from alt
In malignant breast cancer, estrogen metabolism is altered, favoring the accumulation of hydroxyestradiols, which can generate free radicals. These reactive species can activate matrix metalloproteinases (MMPs), which in turn can hydrolyze the proteins of the extracellular matrix (ECM) that act as a